
Matthew Ercolino
Articles
-
2 weeks ago |
bioprocessonline.com | Junwei Sun |Lucia Fernandez |Lucia Fernández |Matthew Ercolino |Jonathan Rocher
Take a tour of Nanoform's best-in-class nanodevelopment capabilities, setting new standards in innovation. Their highly specialized team excels in creating unique nanoparticles for both small and large molecule APIs. With 14 development lines for small molecules and 5 for large molecules, Nanoform offers unmatched scalability and precision. Leveraging cutting-edge technology, they produce nanoformed materials as small as 10 nanometers.
-
3 weeks ago |
cellandgene.com | ajaz Hussain |Junwei Sun |Lucia Fernandez |Lucia Fernández |Matthew Ercolino
Pharmaceutical sovereignty is no longer a theoretical concern. Sovereignty in this context does not imply isolation, but rather strategic resilience: building robust national and regional capabilities that ensure security while enabling global collaboration. Utilizing Quantitative PCR For The Assessment Of AAV SheddingExplore AAV shedding assessment using qPCR, featuring experts discussing assay development, monitoring challenges, and ensuring safety in clinical studies.
-
1 month ago |
bioprocessonline.com | Nero Haralalka |Junwei Sun |Lucia Fernandez |Lucia Fernández |Matthew Ercolino
Multispecific molecules bring added complexity to downstream purification—think incorrect chain pairings, aggregation, fragmentation, and lower yields. Join Bioprocess Online Live as we explore how developers are addressing these challenges to achieve high purity and efficient processes. Gain insights into key considerations for downstream teams when designing purification strategies for these advanced biologics. Registration is free thanks to the support of Thermo Fisher Scientific.
-
1 month ago |
cellandgene.com | Nero Haralalka |Junwei Sun |Lucia Fernandez |Lucia Fernández |Matthew Ercolino
The ISCT 2025 Scientific Annual Meeting (May 7-10 in New Orleans) is the largest global gathering for KOLs and subject matter experts for driving the clinical translation of cell and gene therapies. The work presented at this conference spans regulatory affairs, workforce development and the entire development pathway from pre-clinical work to Phase 3 clinical trials, CGT product launch and market access.
-
2 months ago |
bioprocessonline.com | Pooja Sharma |Junwei Sun |Lucia Fernandez |Lucia Fernández |Matthew Ercolino
Webinar: Minimizing your Risk in RNA-lipid Nanoparticle (LNP) Encapsulation and Drug Product Manufacturing Through a Holistic ApproachJoin us on March 31st to discover how Lonza's platform-based strategy ensures stability, efficacy, and quality in LNP Drug Products with nucleic acid payloads. Learn about critical process challenges in encapsulation, filtration, and aseptic filling, and how to proactively mitigate risks for successful GMP batch manufacturing.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →